Vaxil Bio (TSXV:VXL) Accounts Payable & Accrued Expense : C$0.09 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Accounts Payable & Accrued Expense?

Vaxil Bio's quarterly accounts payable & accrued expense declined from Jun. 2023 (C$0.23 Mil) to Sep. 2023 (C$0.19 Mil) and declined from Sep. 2023 (C$0.19 Mil) to Dec. 2023 (C$0.09 Mil).

Vaxil Bio's annual accounts payable & accrued expense declined from Dec. 2021 (C$0.59 Mil) to Dec. 2022 (C$0.41 Mil) and declined from Dec. 2022 (C$0.41 Mil) to Dec. 2023 (C$0.09 Mil).

Vaxil Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Vaxil Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Accounts Payable & Accrued Expense Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.71

0.59

0.41

0.09

Vaxil Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.41	0.35	0.23	0.19	0.09

Vaxil Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Vaxil Bio (TSXV:VXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

VXLLF:USA

Address

C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Executives

Gadi Levin

Director, Senior Officer

Vaxil Bio (TSXV:VXL) Headlines

No Headlines